Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
OGEN	Oragenics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.84M	n/a	-118.9%	n/a	-$4.56
OGN	Organon & Co. Manufacturing · Year ended 2025-12-31 · USD	$6.22B	$187.00M	3.0%	24.9%	-2.9%	$0.72
OKUR	OnKure Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.52M	n/a	-105.9%	n/a	-$4.40
OLMA	Olema Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$162.45M	n/a	-33.9%	n/a	-$1.87
OMER	Omeros Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.35M	n/a	n/a	n/a	-$0.05
ONC	BeOne Medicines Ltd. Manufacturing · Year ended 2025-12-31 · USD	$5.34B	$286.93M	5.4%	6.6%	40.2%	$0.19
ONCO	Onconetix, Inc. Manufacturing · Year ended 2025-12-31 · USD	$815.4K	-$14.03M	n/m	-89.0%	-67.7%	-$16.56
ONCY	Oncolytics Biotech Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.76M	n/a	n/a	n/a	-$0.30
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
ORGO	Organogenesis Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$564.17M	$37.03M	6.6%	12.3%	17.0%	$0.15
ORIC	Oric Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$129.47M	n/a	-33.7%	n/a	-$1.47
ORKA	Oruka Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.43M	n/a	-22.3%	n/a	n/a
ORMP	Oramed Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$64.05M	n/a	32.1%	n/a	$1.50
OSTX	OS Therapies Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.75M	n/a	n/a	n/a	-$0.98
OTLC	Oncotelic Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$249.28M	n/a	94.9%	n/a	$0.59
OVID	Ovid Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.25M	-$17.41M	-240.1%	-13.3%	n/m	n/a
PAHC	Phibro Animal Health Corp Manufacturing · Year ended 2026-06-30 · USD	$1.52B	$99.72M	6.6%	25.9%	17.1%	$2.43
PBH	Prestige Consumer Healthcare Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.09B	$190.30M	17.5%	10.1%	-4.3%	$3.91
PBYI	Puma Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$228.37M	$31.11M	13.6%	23.9%	-0.9%	$0.61
PCRX	Pacira BioSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$726.41M	$7.03M	1.0%	1.0%	3.6%	$0.16
PCSA	Processa Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.56M	n/a	-243.2%	n/a	-$10.36
PDSB	PDS Biotechnology Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.50M	n/a	-372.9%	n/a	-$0.74
PEPG	PepGen Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$89.66M	n/a	-60.8%	n/a	-$2.12
PFE	Pfizer Inc Manufacturing · Year ended 2025-12-31 · USD	$62.58B	$7.77B	12.4%	9.0%	-1.6%	$1.36
PGEN	Precigen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$250.64M	n/m	n/m	146.7%	-$1.37

Rows per page: 2550 100